Pimavanserin
Specifications
706779-91-1CAS Number
1-[(4-fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-[[4-(2-methylpropoxy)phenyl]methyl]ureaIUPAC Name
C25H34FN3O2Chemical Formula
427.6 g/molMolecular Weight
Pimavanserin; 706779-91-1; ACP-103; pimavanserina; pimavanserine; JZ963P0DIK; CHEBI:133017; DTXSID90990906; N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide; ACP 103; 1-[(4-fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-[[4-(2-methylpropoxy)phenyl]methyl]urea; N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide; 1-[(4-fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-{[4-(2-methylpropoxy)phenyl]methyl}urea; pimavanserinum; 1-((4-fluorophenyl)methyl)-1-(1-methylpiperidin-4-yl)-3-((4-(2-methylpropoxy)phenyl)methyl)urea; RefChem:59074; ACP103; DTXCID70206052; N05AX17; 1-(4-Fluorobenzyl)-3-(4-isobutoxybenzyl)-1-(1-methylpiperidin-4-yl)urea; Pimavanserin [INN]; Pimavanserin free base; MFCD09953792; N-[(4-Fluorophenyl)methyl]-N-(1-methyl-4-piperidinyl)-N''-[[4-(2-methylpropoxy)phenyl]methyl]urea; A1L11; N-[(4-fluorophenyl)methyl]-N-(1-methylpiperidin-4-yl)-N'-{[4-(2-methylpropoxy)phenyl]methyl}urea; UNII-JZ963P0DIK; Pimanavserin; C25H34FN3O2; N-[(4-Fluorophenyl)methyl]-N-(1-methyl-4-piperidinyl)-N'-[[4-(2-methylpropoxy)phenyl]methyl]-urea; N-(4-Fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-[[4-(2-methylpropyloxy)phenyl]methyl]carbamide; Pimavanserin; 706779-91-1 (free base); AC-5273; Pimavanserin (Standard); PIMAVANSERIN [MI]; Pimavanserin(ACP-103); Pimavanserin(ACP-103)?; PIMAVANSERIN [WHO-DD]; SCHEMBL675165; Nuplazid (proposed trade name); GTPL8423; orb1224181; orb1306543; CHEMBL2111101; RKEWSXXUOLRFBX-UHFFFAOYSA-N; BDBM139370; GLXC-10713; HMS3742A03; EX-A4895; EBC-27063; HY-14557R; AKOS015902593; N-[(4-Fluorophenyl)methyl]-N-(1-; CS-3378; DB05316; FP27045; ME-0240; SB16963; 1-[(4-fluorophenyl)methyl]-3-[(4-isobutoxyphenyl)methyl]-1-(1-methyl-4-piperidyl)urea; NCGC00390656-01; NCGC00390656-02; NCGC00390656-04; HY-14557; SY065361; NS00071545; EN300-19659487; F857156; Q7194603; BRD-K83405785-001-01-5; 1-(4-Fluorobenzyl)-3-(4-isobutoxybenzyl)-1-(1-methyl-4-piperidyl)urea; N-(4-Fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-[[4-(2-methylpropyloxy)phenyl]methyl]carbamideSynonyms
Products Containing Pimavanserin
Pimavanserin Tartrate - MSN LaboratoriesPimavanserin Tartrate - Zydus LifesciencesPimavanserin Tartrate - Biophore India Pharmaceuticals Pvt LtdPimavanserin Tartrate - PolpharmaPimavanserin Tartrate - Interquim SAPimavanserin Tartrate - SMS PharmaceuticalsPimavanserin TartratePimavanserinPimavanserinPimavanserin